Evaluating LP-10 in Subjects With OLP
Trial details
- Registry ID
- NCT06233591
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Evaluating LP-10 in Subjects With OLPNCT06233591 | Lipella Pharmaceuticals, Inc. | Phase 2 | Unknown | 2025-06-01Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |